Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin vs acetaminophen for postoperative pain after minimally invasive cholecystectomy
KCT0011930Phase 4Recruiting
- Sponsor
- Yonsei University Health System
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of opiranserin in cholecystitis (2 arms), sponsored by Yonsei University Health System. Started May 2026; status: recruiting.
02
Drugs
opiranserin
03
Conditions
cholecystitis
Beyond the preview
Go deeper on KCT0011930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011930.